Key points are not available for this paper at this time.
Allogeneic red cell transfusion often is required for small patients with underlying neuromuscular disease who undergo extensive spinal fusion surgery. These patients may be less able to donate autologous blood before surgery. Newer therapies to reduce blood loss and transfusion requirement are needed most for this population.
Meert et al. (Tue,) studied this question.